These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 31673702)

  • 21. Marginal structural models for the estimation of the risk of Diabetes Mellitus in the presence of elevated depressive symptoms and antidepressant medication use in the Women's Health Initiative observational and clinical trial cohorts.
    Frisard C; Gu X; Whitcomb B; Ma Y; Pekow P; Zorn M; Sepavich D; Balasubramanian R
    BMC Endocr Disord; 2015 Oct; 15():56. PubMed ID: 26458393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Postmenopausal breast cancer risk and interactions between body mass index, menopausal hormone therapy use, and vitamin D supplementation: Evidence from the E3N cohort.
    Cadeau C; Fournier A; Mesrine S; Clavel-Chapelon F; Fagherazzi G; Boutron-Ruault MC
    Int J Cancer; 2016 Nov; 139(10):2193-200. PubMed ID: 27451078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Current Topics on Vitamin D. Combined therapy of anti-resorptive drug and active vitamin D].
    Endo I
    Clin Calcium; 2015 Mar; 25(3):433-8. PubMed ID: 25716817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. De novo post-diagnosis statin use, breast cancer-specific and overall mortality in women with stage I-III breast cancer.
    Smith A; Murphy L; Sharp L; O'Connor D; Gallagher WM; Bennett K; Barron TI
    Br J Cancer; 2016 Aug; 115(5):592-8. PubMed ID: 27482648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Are oral bisphosphonates effective in improving lumbar bone mineral density in breast cancer survivors with osteopenia or osteoporosis?
    Sawka AM; Ioannidis G; Papaioannou A; Thabane L; Olszynski WP; Brown JP; Hanley DA; Murray TM; Josse RG; Sebaldt RJ; Petrie A; Tenenhouse A; Goldsmith CH; Boulos P; Kouroukis T; Adachi JD
    J Obstet Gynaecol Can; 2005 Aug; 27(8):759-64. PubMed ID: 16287007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hormone replacement therapy after a diagnosis of breast cancer in relation to recurrence and mortality.
    O'Meara ES; Rossing MA; Daling JR; Elmore JG; Barlow WE; Weiss NS
    J Natl Cancer Inst; 2001 May; 93(10):754-62. PubMed ID: 11353785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between bisphosphonate therapy and outcomes from rehabilitation in older people.
    Goodbrand JA; Hughes LD; Cochrane L; Donnan PT; McGilchrist M; Frost H; McMurdo ME; Witham MD
    Arch Gerontol Geriatr; 2017; 70():195-200. PubMed ID: 28214400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-Term Oral Bisphosphonate Therapy and Fractures in Older Women: The Women's Health Initiative.
    Drieling RL; LaCroix AZ; Beresford SAA; Boudreau DM; Kooperberg C; Chlebowski RT; Ko MG; Heckbert SR
    J Am Geriatr Soc; 2017 Sep; 65(9):1924-1931. PubMed ID: 28555811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of statistical approaches dealing with time-dependent confounding in drug effectiveness studies.
    Karim ME; Petkau J; Gustafson P; Platt RW; Tremlett H;
    Stat Methods Med Res; 2018 Jun; 27(6):1709-1722. PubMed ID: 27659168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum 25-hydroxyvitamin D, vitamin A, and lung cancer mortality in the US population: a potential nutrient-nutrient interaction.
    Cheng TY; Neuhouser ML
    Cancer Causes Control; 2012 Sep; 23(9):1557-65. PubMed ID: 22829430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral bisphosphonate use and the risk of female breast, ovarian, and cervical cancer: a nationwide population-based cohort study.
    Bae YS; Chang J; Park SM
    Arch Osteoporos; 2019 Mar; 14(1):41. PubMed ID: 30888545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preadmission Bisphosphonate and Mortality in Critically Ill Patients.
    Lee P; Ng C; Slattery A; Nair P; Eisman JA; Center JR
    J Clin Endocrinol Metab; 2016 May; 101(5):1945-53. PubMed ID: 26780569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening status, tumour subtype, and breast cancer survival: a national population-based analysis.
    O'Brien KM; Mooney T; Fitzpatrick P; Sharp L
    Breast Cancer Res Treat; 2018 Nov; 172(1):133-142. PubMed ID: 30006795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Marginal structural model to evaluate the association between cumulative osteoporosis medication and infection using claims data.
    Xue F; Goli V; Petraro P; McMullan T; Sprafka JM; Tchetgen Tchetgen EJ
    Osteoporos Int; 2017 Oct; 28(10):2893-2901. PubMed ID: 28685279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. G-estimation of structural nested restricted mean time lost models to estimate effects of time-varying treatments on a failure time outcome.
    Hagiwara Y; Shinozaki T; Matsuyama Y
    Biometrics; 2020 Sep; 76(3):799-810. PubMed ID: 31829432
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The association between glucose-lowering drug use and mortality among breast cancer patients with type 2 diabetes.
    Vissers PA; Cardwell CR; van de Poll-Franse LV; Young IS; Pouwer F; Murray LJ
    Breast Cancer Res Treat; 2015 Apr; 150(2):427-37. PubMed ID: 25762476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating 25-hydroxyvitamin D and postmenopausal breast cancer survival: Influence of tumor characteristics and lifestyle factors?
    Vrieling A; Seibold P; Johnson TS; Heinz J; Obi N; Kaaks R; Flesch-Janys D; Chang-Claude J
    Int J Cancer; 2014 Jun; 134(12):2972-83. PubMed ID: 24272459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Post-hip fracture use of prescribed calcium plus vitamin D or vitamin D supplements and antiosteoporotic drugs is associated with lower mortality: a nationwide study in Finland.
    Nurmi-Lüthje I; Sund R; Juntunen M; Lüthje P
    J Bone Miner Res; 2011 Aug; 26(8):1845-53. PubMed ID: 21351147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence of hematologic malignancy and cause-specific mortality in the Women's Health Initiative randomized controlled trial of calcium and vitamin D supplementation.
    Ammann EM; Drake MT; Haraldsson B; Wallace RB; Johnson KC; Desai P; Lin EM; Link BK
    Cancer; 2017 Nov; 123(21):4168-4177. PubMed ID: 28654155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost effectiveness of fracture prevention in postmenopausal women who receive aromatase inhibitors for early breast cancer.
    Ito K; Blinder VS; Elkin EB
    J Clin Oncol; 2012 May; 30(13):1468-75. PubMed ID: 22370313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.